A comprehensive view of Approved Drugs / Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Medtronic's OsteoCool 2.0 bone tumor ablation system gets FDA clearance; the device is designed to increase flexibility and efficiency in treating painful bone metastases and benign bone tumors

Boston Scientific receives FDA approval for drug-coated balloon to treat coronary in-stent restenosis, a common heart condition causing artery narrowing; the device represents a US$500.0M global market opportunity

Nevro receives FDA 501(k) clearance for sacroiliac joint fusion device Nevro1, enabling the company to expand into the chronic SI joint pain treatment market; the market is projected to surpass US$2.0B by 2032

Janssen Pharmaceutical Companies Secures FDA Approval for NSCLC Therapy and Champions Cardiac Health Equity

Biosense Webster announces CE Mark approval in Europe for VARIPULSE Pulsed Field Ablation platform; platform is integrated with the CARTO 3D cardiac mapping system to treat symptomatic drug refractory recurrent paroxysmal atrial fibrillation

Ask us about our Bioeconomy market view

Trending Chart

Interactive chart with headline count